Cowealth Medical China Co.,Ltd. (SHA:603122)

Cowealth Medical China Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	776.67	938.79	1,092	1,279	1,191	1,089
Other Revenue	0.35	0.35	0.33	0.33	0.32	0.28
Revenue	777.03	939.14	1,093	1,280	1,191	1,089
Revenue Growth (YoY)	-19.93%	-14.05%	-14.62%	7.44%	9.37%	4.02%
Cost of Revenue	655.44	763.98	870.46	1,024	943.35	866.08
Gross Profit	121.59	175.16	222.14	255.43	247.71	222.95
Selling, General & Admin	123.08	147.76	158.86	147.54	139.23	111.33
Research & Development	3.6	3.75	3.18	2.8	-	-
Other Operating Expenses	4.8	-1.18	-1.49	3.75	3.45	2.79
Operating Expenses	129.08	140.09	157.67	156.56	145.67	128.85
Operating Income	-7.49	35.07	64.48	98.87	102.03	94.09
Interest Expense	-0.4	-3.32	-5.88	-4.24	-4.55	-3.37
Interest & Investment Income	0.96	4.15	9.34	9.77	4.67	6
Currency Exchange Gain (Loss)	0.92	0.92	-0.03	0.78	-0.22	0.99
Other Non Operating Income (Expenses)	-9.98	0.31	-3.88	-0.27	0.76	-1.13
EBT Excluding Unusual Items	-15.99	37.13	64.04	104.91	102.69	96.57
Gain (Loss) on Sale of Investments	-1.15	-1.15	-1.38	-	-	-
Gain (Loss) on Sale of Assets	0.41	0.42	0.08	-0.16	-0	0.04
Asset Writedown	-0.87	-	-	-	-	-
Other Unusual Items	5.44	3.07	2.96	9.1	6.83	1.95
Pretax Income	-12.16	39.47	65.7	113.84	109.52	98.57
Income Tax Expense	-1.46	11	18.54	31.13	29.35	26.01
Earnings From Continuing Operations	-10.7	28.47	47.16	82.72	80.16	72.55
Minority Interest in Earnings	-0.67	-0.9	0.03	0	0.07	-
Net Income	-11.37	27.57	47.19	82.72	80.23	72.55
Net Income to Common	-11.37	27.57	47.19	82.72	80.23	72.55
Net Income Growth	-	-41.58%	-42.96%	3.10%	10.58%	8.06%
Shares Outstanding (Basic)	419	394	393	376	297	302
Shares Outstanding (Diluted)	419	394	393	376	297	302
Shares Change (YoY)	11.07%	0.15%	4.58%	26.53%	-1.71%	17.06%
EPS (Basic)	-0.03	0.07	0.12	0.22	0.27	0.24
EPS (Diluted)	-0.03	0.07	0.12	0.22	0.27	0.24
EPS Growth	-	-41.67%	-45.45%	-18.52%	12.50%	-7.69%
Free Cash Flow	222.08	100.93	-56.68	-56.31	-15.11	66.05
Free Cash Flow Per Share	0.53	0.26	-0.14	-0.15	-0.05	0.22
Dividend Per Share	0.130	0.130	0.060	0.150	0.180	-
Dividend Growth	116.67%	116.67%	-60.00%	-16.67%	-	-
Gross Margin	15.65%	18.65%	20.33%	19.96%	20.80%	20.47%
Operating Margin	-0.96%	3.73%	5.90%	7.73%	8.57%	8.64%
Profit Margin	-1.46%	2.94%	4.32%	6.46%	6.74%	6.66%
Free Cash Flow Margin	28.58%	10.75%	-5.19%	-4.40%	-1.27%	6.07%
EBITDA	-0.44	42.17	71.65	106.92	112.66	109.78
EBITDA Margin	-0.06%	4.49%	6.56%	8.36%	9.46%	10.08%
D&A For EBITDA	7.05	7.1	7.17	8.05	10.63	15.69
EBIT	-7.49	35.07	64.48	98.87	102.03	94.09
EBIT Margin	-0.96%	3.73%	5.90%	7.73%	8.57%	8.64%
Effective Tax Rate	-	27.87%	28.21%	27.34%	26.80%	26.39%
Revenue as Reported	228.17	939.14	1,093	1,280	1,191	1,089
Advertising Expenses	-	4.06	3.61	4.65	2.32	4.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.